Chemical markers for the quality control of herbal medicines: an overview
Tóm tắt
Selection of chemical markers is crucial for the quality control of herbal medicines, including authentication of genuine species, harvesting the best quality raw materials, evaluation of post-harvesting handling, assessment of intermediates and finished products, and detection of harmful or toxic ingredients. Ideal chemical markers should be the therapeutic components of herbal medicines. However, for most herbal medicines, the therapeutic components have not been fully elucidated or easily monitored. Bioactive, characteristic, main, synergistic, correlative, toxic and general components may be selected. This article reviews the effective use of chemical markers in the quality control of herbal medicines including the selection criteria considering the roles and physicochemical factors which may affect the effective use of chemical markers.
Từ khóa
Tài liệu tham khảo
World Health Organization: Traditional medicine. [http://www.who.int/mediacentre/factsheets/fs134/en/]
The European Medicines Agency: Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products. [http://www.emea.europa.eu/pdfs/human/hmpc/25362907en.pdf]
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 8-11. A123-25.
Roy Upton RH: American Herbal Pharmacopoeia. [http://www.herbal-ahp.org/]
Srinivasan VS: Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program – a public health program. Life Sci. 2006, 78: 2039-43.
Chan SSK, Li SL, Lin G: Pitfalls of the selection of chemical markers for the quality control of medicinal herbs. J Food Drug Anal. 2007, 15: 365-71.
Li HJ, Jiang Y, Li P: Chemistry, bioactivity and geographical diversity of steroidal alkaloids from the Liliaceae family. Nat Prod Rep. 2006, 23: 735-52.
Lin BQ, Ji H, Li P, Fang W, Jiang Y: Inhibitors of acetylcholine esterase in vitro – screening of steroidal alkaloids from Fritillaria species. Planta Med. 2006, 72: 814-8.
Lin BQ, Ji H, Li P, Jiang Y, Fang W: Selective antagonism activity of alkaloids from Bulbs Fritillariae at muscarinic receptors: functional studies. Eur J Pharmacol. 2006, 551: 125-30.
Lin G, Li P, Li SL, Chan SW: Chromatographic analysis of Fritillaria isosteroidal alkaloids, the active ingredients of Beimu, the antitussive traditional Chinese medicinal herb. J Chromatogr A. 2001, 935: 321-38.
Lee S: Artemisinin, promising lead natural product for various drug developments. Mini Rev Med Chem. 2007, 7: 411-22.
China Collaborative Research Group: Antimalaria studies on Qinghaosu. Chin Med J (Engl). 1979, 92: 811-6.
Dhingra V, Rao KV, Narasu ML: Current status of artemisinin and its derivatives as antimalaria drugs. Life Sci. 2000, 66: 279-300.
Liu CZ, Zhou HY, Zhao Y: An effective method for fast determination of artemisinin in Artemisia annua L. by high performance liquid chromatography with evaporative light scattering detection. Anal Chim Acta. 2007, 581: 298-302.
Ma C, Wang H, Lu X, Xu G, Liu B: Metabolic fingerprinting investigation of Artemisia annua L. in different stages of development by gas chromatography and gas chromatography-mass spectrometry. J Chromatogr A. 2008, 1186: 412-419.
Lommen WJ, Elzinga S, Verstappen FW, Bouwmeester HJ: Artemisinin and sesquiterpene precursors in dead and green leaves of Artemisia annua L. crops. Planta Med. 2007, 73: 1133-9.
Zhen HZ, Dong ZH, She Q: Modern study of traditional Chinese medicine. 1998, Beijing: Xueyuan Publications, 4: 3883-942.
Song JZ, Mo SF, Yip YK, Qiao CF, Han QB, Xu HX: Development of microwave assisted extraction for the simultaneous determination of isoflavonoids and saponins in Radix Astragali by high performance liquid chromatography. J Sep Sci. 2007, 30: 819-24.
Yu QT, Qi LW, Li P, Yi L, Zhao J, Bi Z: Determination of seventeen main flavonoids and saponins in the medicinal plant Huang-qi (Radix Astragali) by HPLC-DAD-ELSD. J Sep Sci. 2007, 30: 1292-9.
Zhang X, Xiao HB, Xue XY, Sun YG, Liang XM: Simultaneous characterization of isoflavonoids and astragalosides in two Astragalus species by high-performance liquid chromatography coupled with atmospheric pressure chemical ionization tandem mass spectrometry. J Sep Sci. 2007, 30: 2059-69.
Sarris J: Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytother Res. 2007, 21: 703-16.
Butterweck V: Mechanism of action of St John's wort in depression: what is known?. CNS Drugs. 2003, 17: 539-62.
Butterweck V, Schmidt M: St. John's wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr. 2007, 157: 356-61.
Noldner M, Schota K: Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 2002, 68: 577-80.
Liu F, Pan C, Drumm P, Ang CY: Liquid chromatography-mass spectrometry studies of St. John's wort methanol extraction: active constituents and their transformation. J Pharm Biomed Anal. 2005, 37: 303-12.
Shah AK, Avery BA, Wyandt CM: Content analysis and stability evaluation of selected commercial preparations of St. John's wort. Drug Dev Ind Pharm. 2005, 31: 907-16.
Chandrasekera DH, Welham KJ, Ashton D, Middleton R, Heinrich M: Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS. J Pharm Pharmacol. 2005, 57: 1645-52.
Smelcerovic A, Spiteller M, Zuehlke S: Comparison of methods for the exhaustive extraction of hypericins, flavonoids and hyperforin from Hypericum perforatum L. J Agric Food Chem. 2006, 54: 2750-3.
Rückert U, Likussar W, Michelitsch A: Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection. Phytochem Anal. 2007, 18: 204-8.
Van Beek TA: Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A. 2002, 967: 21-55.
Ding S, Dudley E, Plummer S, Tang J, Newton RP, Brenton AG: Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 2753-60.
Croom E, Pace R, Paletti A, Sardone N, Gray DE: Single-laboratory validation for the determination of terpene lactones in Ginkgo biloba dietary supplement crude materials and finished products by high-performance liquid chromatography with evaporative light-scattering detection. J AOAC Int. 2007, 90: 647-58.
Gray DE, Messer D, Porter A, Hefner B, Logan D, Harris RK, Clark AP, Algaier JA, Overstreet JD, Smith CS: Analysis of flavonol aglycones and terpene lactones in Ginkgo biloba extract: A comparison of high-performance thin-layer chromatography and column high-performance liquid chromatography. J AOAC Int. 2007, 90: 1203-9.
Bent S, Padula A, Moore D, Patterson M, Mehling W: Valerian for sleep: a systematic review and meta-analysis. Am J Med. 2006, 119: 1005-12.
Taibi DM, Landis CA, Petry H, Vitiello MV: A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev. 2007, 11: 209-30.
Shohet D, Wills RB, Stuart DL: Valepotriates and valerenic acids in commercial preparations of valerian available in Australia. Pharmazie. 2001, 56: 860-3.
Torrado JJ: In vitro release of valerenic and hydroxyvalerenic acids from valerian tablets. Pharmazie. 2003, 58: 636-8.
Goppel M, Franz G: Stability control of valerian ground material and extracts: a new HPLC method for the routine quantification of valerenic acids and lignans. Pharmazie. 2004, 59: 446-52.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 205-206. 209, 223.
Guan J, Lai CM, Li SP: A rapid method for the simultaneous determination of 11 saponins in Panax notoginseng using ultra performance liquid chromatography. J Pharm Biomed Anal. 2007, 44: 996-1000.
Kim SN, Ha YW, Shin H, Son SH, Wu SJ, Kim YS: Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control. J Pharm Biomed Anal. 2007, 45: 164-70.
Wan JB, Li SP, Chen JM, Wang YT: Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. J Sep Sci. 2007, 30: 825-32.
Chan TWD, But PPH, Cheng SW, Kwok IMY, Lan FW, Xu HX: Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. Anal Chem. 2000, 72: 1281-7.
Wang XM, Sakuma T, Asafu-adjaye E, Shiu GK: Determination of gingsenosides in plant extracts from Panax ginseng and Panax quinquefolius by LC/MS/MS. Anal Chem. 1999, 71: 1579-84.
Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS: Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 2007, 73: 669-74.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 134
Pei LK, Guo BL: A review on research of raw material and cut crude drug of Herba Epimedii in last ten years (Chinese). Zhongguo Zhongyao Zazhi. 2007, 32: 466-71.
Zhang G, Qin L, Shi Y: Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res. 2007, 22: 1072-9.
Chen XJ, Guo BL, Li SP, Zhang QW, Tu PF, Wang YT: Simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and high-performance liquid chromatography. J Chromatogr A. 2007, 1163: 96-104.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 107
Qiao CF, Han QB, Mo SF, Song JZ, Xu LJ, Chen SL, Yang DJ, Kong LD, Kung HF, Xu HX: Psoralenoside and isopsoralenoside, two new benzofuran glycosides from Psoralea corylifolia. Chem Pharm Bull. 2006, 54: 714-6.
Qiao CF, Han QB, Song JZ, Mo SF, Kong LD, Kung HF, Xu HX: Quality assessment of Fructus Psoraleae. Chem Pharm Bull. 2006, 54: 887-90.
Cosyns JP: Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Safety. 2003, 26: 33-48.
Fu PP, Xia QS, Lin G, Chou MW: Pyrrolizidine alkaloids – genotoxicity, metabolism enzymes, metabolic action, and mechanisms. Drug Metab Rev. 2004, 36: 1-55.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: XXI
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 201
Chan W, Lee KC, Liu N, Cai Z: A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines. J Chromatogr A. 2007, 1164: 113-9.
Yuan J, Liu Q, Wei G, Tang F, Ding L, Yao S: Characterization and determination of six aristolochic acids and three aristololactams in medicinal plants and their preparations by high-performance liquid chromatography-photodiode array detection/electrospray ionization massspectrometry. Rapid Commun Mass Spectrom. 2007, 21: 2332-42.
Sorenson WR, Sullivan D: Determination of aristolochic acid I in botanicals and dietary supplements potentially contaminated with aristolochic acid I using LC-UV with confirmation by LC/MS: collaborative study. J AOAC Int. 2007, 90: 925-33.
Shi S, Li W, Liao Y, Cai Z, Liu H: Online concentration of aristolochic acid I and II in Chinese medicine preparations by micellar electrokinetic chromatography. J Chromatogr A. 2007, 1167: 120-4.
Röder E: Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie. 2000, 55: 711-23.
World Health Organization: Health and Safety Guide No.26: Pyrrolizidine alkaloids health and safety guide. 1989, 1-17.
Dharmananda S: Safety issue affecting herbs: pyrrolizidine alkaloids. [http://www.itmonline.org/arts/pas.htm]
Medicines and Healthcare Products Regulatory Agency: Public consultation: Proposals to prohibit the sale, supply or importation of unlicensed medicinal products for internal use which contain Senecio species and proposals to amend three existing orders. [http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE0026;dDocName=CON20307490026;RevisionSelectionMethod=LatestReleased]
Colegate SM, Edgar JA, Knill AM, Lee ST: Solid-phase extraction and HPLC-MS profiling of pyrrolizidine alkaloids and their N-oxides: a case study of Echium plantagineum. Phytochem Anal. 2005, 16: 108-19.
Yu L, Xu Y, Feng H, Li SF: Separation and determination of toxic pyrrolizidine alkaloids in traditional Chinese herbal medicines by micellar electrokinetic chromatography with organic modifier. Electrophoresis. 2005, 26: 3397-404.
Chou MW, Fu PP: Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids. Toxicol Ind Health. 2006, 22: 321-7.
Ndjoko K, Wolfender JL, Röder E, Hostettmann K: Determination of pyrrolizidine alkaloids in senecio species by liquid chromatography/thermospray-mass spectrometry and liquid chromatography/nuclear magnetic resonance spectroscopy. Planta Med. 1999, 65: 562-6.
Zhang F, Wang CH, Xiong AZ, Wang W, Yang L, Branford-White CJ, Wang ZT, Bligh SW: Quantitative analysis of total retronecine esters-type pyrrolizidine alkaloids in plant by high performance liquid chromatography. Anal Chim Acta. 2007, 605: 94-101.
Zhang F, Wang CH, Wang W, Chen LX, Ma HY, Zhang CF, Zhang M, Bligh SW, Wang ZT: Quantitative analysis by HPLC-MS2 of the pyrrolizidine alkaloid adonifoline in Senecio scandens. Phytochem Anal. 2007, 19 (1): 25-31.
Li SL, Lin G, Fu PP, Chan CL, Li M, Jiang ZH, Zhao ZZ: Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis Scandentis (Qianliguang). Rapid Commun Mass spectrom. 2008, 22 (4): 598-602.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 197
Qiao CF, He ZD, Han QB, Xu HX, Jiang RW, Li SL, Zhang YB, But PPH, Shaw PC: The use of lobetyolin and HPLC-UV fingerprints for quality assessment of Radix Codonopsis. J Food Drug Aanal. 2007, 15: 258-64.
Jiangsu New Medical College: Dictionary of Chinese Traditional Medicines. 1977, Shanghai: Shanghai Scientific and Technical Publishers, 3805-07.
Panthong A, Norkaew P, Kanjanapothi D, Taesotikul T, Anantachoke N, Reutrakul V: Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboges from Garcinia hanburyi Hook f. J Ethnopharmacol. 2007, 111: 335-40.
Han Q, Yang L, Liu Y, Wang Y, Qiao C, Song J, Xu L, Yang D, Chen S, Xu H: Gambogic acid and epigambogic acid, C-2 epimers with novel anticancer effects from Garcinia hanburyi. Planta Med. 2006, 72: 281-4.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 239
Greger H: Structural relationships, distribution and biological activities of stemona alkaloids. Planta Med. 2006, 72: 99-113.
Pilli RA, Ferreira de Oliveira MC: Recent progress in the chemistry of the Stemona alkaloids. Nat Prod Rep. 2000, 17: 117-27.
Xu YT, Hon PM, Jiang RW, Cheng L, Li SH, Chan YP, Xu HX, Shaw PC, But PP: Antitussive effects of Stemona tuberosa with different chemical profiles. J Ethnopharmacol. 2006, 108: 46-53.
Chung HS, Hon PM, Lin G, But PP, Dong H: Antitussive activity of Stemona alkaloids from Stemona tuberosa. Planta Med. 2003, 69: 914-20.
Li SL, Jiang RW, Hon PM, Cheng L, Xu HX, Greger H, But PP, Shaw PC: Quality evaluation of Radix Stemonae through simultaneous quantification of bioactive alkaloids by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. Biomed Chromatogr. 2007, 21: 1088-94.
Zhou Y, Jiang RW, Hon PM, Xu YT, Chan YM, Chan TW, Xu HX, Ding LS, But PP, Shaw PC: Analyses of Stemona alkaloids in Stemona tuberosa by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 1030-8.
Wang PS, Gao YX, Wang YX, Yoshiyasu F, Iwao M, Michiharu S: Phthalides from the rhizome of Ligusticum wallichi. Phytochemistry. 1984, 23: 2033-8.
Wang PS: Survey of investigation on chemical principles and biological activities of Ligusticum wallichi (Chinese). Zhongguo Yiyao Gongye. 1988, 19: 553-9.
Kobayashi M, Fujita M, Mitsuhashi H: Studies on the constituents of Umbelliferae plants. XV. Constituents of Cnidium officinale: Occurrence of pregnenolone, coniferylferulate and hydroxyphthalides. Chem Pharm Bull. 1987, 35: 1427-33.
Tsuchida T, Kobayashi M, Kaneko K, Mitsuhashi H: Studies on the constituents of Umbelliferae plants. XVI. Isolation and structures of three new ligustilide derivatives from Angelica acutiloba. Chem Pharm Bull. 1987, 35: 4460-4.
Kobayashi M, Mitsuhashi H: Studies on the constituents of Umbelliferae plants XVII: Structures of three new ligustilide derivatives from Ligusticum wallichi. Chem Pharm Bull. 1987, 35: 4789-92.
Kaouadji M, Pachtere F, Pouget C, Chulia AJ: Three additional phthalide derivatives, an epoxymonomer and two dimers, from Ligusticum wallichi rhizomes. J Nat Prod. 1986, 49: 872-7.
Naito T, Katsuhara T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H: Phthalide dimers from Ligusticum chuanxiong Hort. Heterocycles. 1991, 32: 2433-42.
Naito T, Kubota K, Shimoda Y, Sato T, Ikeya Y, Okada M: Effects of constituents in a Chinese crude drug, Ligustici Chuanxiong Rhizoma on vasocontracton and blood viscosity. Nat Med. 1995, 49: 288-92.
Kobayashi S, Mimura Y, Notoya K, Kimura I, Kimura M: Antiproliferative effects of the traditional Chinese medicine Shimotsu-To, its component Cnidium Rhizome and derived compounds on primary cultures of mouse aorta smooth muscle cells. Jap J Pharmacol. 1992, 60: 397-401.
Kobayashi S, Mimura Y, Naito Y, Kimura I, Kimura M: Chemical structure-activity of Cnidium Rhizome – derived phthalides for the competence inhibition of proliferation in primary cultures of mouse aorta smooth muscle cells. Jap J Pharmacol. 1993, 63: 353-9.
Foye WO, Wang HP, Wang HF: Synthesis and platelet aggregation inhibitory effects of Harman and phthalide derivatives related to Ligusticum chuanxiong Hort. constituents. Med Chem Res. 1997, 7: 180-91.
Lee TF, Lin YL, Huang YT: Studies on antiproliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. Planta Med. 2007, 73: 527-34.
Chan SS, Cheng TY, Lin G: Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta. J Ethnopharmacol. 2007, 111: 677-80.
Chan SS, Choi AO, Jones RL, Lin G: Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong, in rat isolated aorta. Eur J Pharmacol. 2006, 537: 111-7.
Li SL, Lin G, Tam YK: Time-course accumulation of main bioactive components in the rhizome of Ligusticum chuanxiong. Planta Med. 2006, 72: 278-80.
Jiang RW, Hon PM, But PPH, Chung HS, Lin G, Ye WC, Mak TCW: Isolation and stereochemistry of two new alkaloids from Stemona tuberosa. Tetrahedron. 2002, 58: 6705-12.
Jiang RW, Hon PM, Zhou Y, Chan YM, Xu YT, Xu HX, Greger H, Shaw PC, But PPH: Alkaloids and chemical diversity of Stemona tuberosa. J Nat Prod. 2006, 69: 749-54.
Jiang RW, Hon PM, Xu YT, Chan YM, Xu HX, Shaw PC, But PPH: Isolation and chemotaxonomic significance of tuberostemospironine-type alkaloids from Stemona tuberosa. Phytochemistry. 2006, 67: 52-57.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 185
Fujita Y, Terui K, Fujita M, Kakizaki A, Sato N, Oikawa K, Aoki H, Takahashi K, Endo S: Five cases of aconite poisoning: toxicokinetics of aconitines. J Anal Toxicol. 2007, 31: 132-7.
Poon WT, Lai CK, Ching CK, Tse KY, So YC, Chan YC, Hau LM, Mak TW, Chan AY: Aconite poisoning in camouflage. Hong Kong Med J. 2006, 12: 456-9.
Lai CK, Poon WT, Chan YW: Hidden aconite poisoning: identification of yunaconitine and related Aconitum alkaloids in urine by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2006, 30: 426-33.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 188
Ohta H, Seto Y, Tsunoda N, Takahashi Y, Matsuura K, Ogasawara K: Determination of Aconitum alkaloids in blood and urine samples II. Capillary liquid chromatographic-frit fast atom bombardment mass spectrometric analysis. J Chromatogr B. 1998, 714: 215-21.
Gutser UT, Friese J, Heubach JF, Matthiesen T, Selve N, Wilffert B, Gleitz J: Mode of antinociceptive and toxic action of alkaloids of Aconitum spec. Naunyn Schmiedebergs Arch Pharmacol. 1998, 357: 39-48.
Xie Y, Jiang ZH, Zhou H, Xu HX, Liu L: Simultaneous determination of six Aconitum alkaloids in proprietary Chinese medicines by high-performance liquid chromatography. J Chromatogr A. 2005, 1093: 195-203.
Song JZ, Mo SF, Yip YK, Qiao CF, Han QB, Xu HX: Chemical comparison and classification of cultivated Radix Astragali in different region of China by determination of isoflavonoids and astragalosides in its bark and xylem with principal component analysis. J Pharm Biomed Anal. 2008, 47: 399-406.
Cai X, Zhou H, Wong YF, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L: Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Bioch Biophy Res Commun. 2005, 337: 586-94.
Zhou H, Wong YF, Cai X, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L: Suppressive effects of JCICM-6, the extracts of an anti-arthritic herbal formula, on the experimental inflammatory and nociceptive models in rodents. Biol Pharm Bull. 2006, 29: 253-60.
Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, Kinne RW: Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol. 1996, 18: 529-43.
Liang J, Zhou A, Chen M, Xu S: Negatively regulatory effects of paeoniflorin on immune cells. Eur J Pharmacol. 1990, 183: 901-02.
Rafatullah S, Tariq M, Al-Yahya MA, Mossa JS, Ageel AM: Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J Ethnopharmacol. 1990, 29: 25-34.
Hikino H, Konno C, Takata H, Yamada Y, Yamada C, Ohizumi Y, Sugio K, Fujimura H: Antiinflammatory principles of Aconitum roots. J Pharmacobiodyn. 1980, 3: 514-25.
Xie Y, Jiang ZH, Zhou H, Cai X, Wong YF, Liu ZQ, Bian ZX, Xu HX, Liu L: Combinative method using HPLC quantitative and qualitative analyses for quality consistency assessment of a herbal medicinal preparation. J Pharm Biomed Anal. 2007, 43: 204-12.
Liu WY, Feng F, You QD, Zhang ZX: Determination of gambogic acid in gamboges by RP-HPLC (Chinese). Zhongcaoyao. 2003, 34: 706-07.
Yang H, Cong XD, Jiang WL, Liu LX: Determination of the content of gambogic acid and its derivatives in gamboges by HPLC-ELSD. J Chin Pharm Univ. 1999, 30: 202-05.
Song JZ, Yip YK, Han QB, Qiao CF, Xu HX: Rapid determination of polyprenylated xanthones in gamboges resin of Garcinia hanburyi by HPLC. J Sep Sci. 2007, 30: 304-09.
Li SL, Song JZ, Han QB, Qiao CF, Xu HX: Improved high performance liquid chromatographic method for simultaneous determination of 12 cytotoxic caged xanthones in gamboges, a potential anticancer resin from Garcinia hanburyi. Biomed Chromatogr. 2008, 22: 637-644.
Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L: General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin. 2004, 25: 769-74.
Yang Y, Yang L, You QD, Nie FF, Gu HY, Zhao L, Wang XT, Guo QL: Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett. 2007, 256: 259-66.
Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY, Zhang HW, Tan Z, Wang X: Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol. 2006, 58: 434-43.
Kasibhatla S, Jessen KA, Maliartchouk S, Wang JY, English NM, Drewe J, Qiu L, Archer SP, Ponce AE, Sirisoma N, Jiang S, Zhang HZ, Gehlsen KR, Cai SX, Green DR, Tseng B: A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA. 2005, 102: 12095-100.
Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB: Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-{kappa} B signaling pathway. Blood. 2007, 110: 3517-25.
Zhou ZT, Wang JW: Phase I human tolerability trial of gambogic acid (Chinese). Chin J New drugs. 2007, 16: 79-82.
Han QB, Cheung S, Tai J, Qiao CF, Song JZ, Xu HX: Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid. Bio Pharm Bull. 2005, 28: 2335-7.
Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2005, Beijing: People's Medical Publishing House, 1: 41
Han QB, Song JZ, Qiao CF, Wong L, Xu HX: Preparative separation of gambogic acid and its C-2 epimer using recycling high-speed counter-current chromatography. J Chromatogr A. 2006, 1127: 298-301.